Cosmos Health (COSM) announced the initiation of a new research and development program leveraging nanotechnology to enhance the effectiveness of phytochemical constituents used in its dietary supplement formulas. “This new initiative builds upon the proprietary know-how developed during the creation of CCX Hydrogel, a breakthrough platform for optimised bioactive delivery. The Company is now expanding its innovation pipeline by developing plant-based extract-loaded phytosomes intended for use in dietary supplements. These nanostructured systems are designed to significantly improve the absorption, stability, and bioactivity of phytochemicals, leading to measurable efficacy improvements,” the company stated.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COSM:
- Cosmos Health acquires additional $200,000 of Ethereum
- Cosmos Health regains compliance with Nasdaq minimum bid price requirement
- Cosmos Health reports purchase of additional $300,000 in Ethereum
- Cosmos Health purchases additional $500,000 worth of Ethereum
- Cosmos Holdings Appoints Theodoros Karkantzos to Board